In a recent interview, FDA Commissioner Marty Makary sparked controversy by urging Americans to consult their doctors regarding Covid-19 vaccines, citing mixed data on their safety for children and pregnant individuals. As the government alters vaccine recommendations, public health experts express concern over potential risks.
In a groundbreaking move, the FDA has approved Moderna's lower-dose Covid-19 vaccine for older adults and at-risk individuals. Get ready for a new option this fall as Moderna targets the LP.8.1 variant!
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, specifically for high-risk groups. This innovative option offers a lower dose while maintaining effectiveness, marking a pivotal step in the fight against coronavirus.
A U.S. government report on children's health has been criticized for citing non-existent studies, raising concerns about its credibility. The White House attributed the errors to formatting issues, but experts suggest reliance on AI may be to blame.
In a surprising move, the Department of Health and Human Services has withdrawn millions in funding for Moderna's bird flu vaccine development, raising concerns about the nation's pandemic preparedness amid ongoing tensions over vaccine safety.
Federal health officials are urging seniors to avoid the Ixchiq vaccine for chikungunya due to serious health risks, including deaths and severe side effects. The CDC is currently investigating these alarming reports.
U.S. health officials have advised patients to pause the Ixchiq vaccine after reports of serious adverse events. Investigations are ongoing as the FDA reassesses its safety for older adults.
American travelers aged 60 and older are advised against the chikungunya vaccine amid concerns over potential side effects. Investigations are underway following reports of serious health issues post-vaccination.
In a groundbreaking move, HHS Secretary Robert F. Kennedy Jr. mandates new vaccines to undergo placebo testing, raising ethical questions and altering vaccine approval protocols. Is this the future of vaccine safety?
